fbpx
我们正在寻找中国人参与临床研究
News
AKL & HAM - 0800 788 3437
CHC & WLG - 0800 862 278

Important Information

Please note, we need you to ….
  • Read the important documents for this study
  • If you are interested, look at the dates that this study is being run (cohort visit planners) and  reply to our email (don’t re-register online) to let us know which cohort(s) you are available for
  • We will ring you to check your suitability and provide further information about the study
  • We will make you a screening appointment at NZCR Auckland. You will need to attend at the scheduled time if you wish to take part in the study

Study Information

RO7565020 is being developed for the treatment of Chronic Hepatitis B (CHB), whereby chronic infection with Hepatitis B virus (HBV) can lead to liver damage and potentially liver cancer. RO7565020 is designed to target and reduce the levels of Hepatitis B surface antigen (HBsAg) in the hopes of providing a functional cure for CHB.

The purpose of part 1a of this study is to:
● Evaluate how safe and well tolerated single doses of RO7565020 is, in healthy participants
● Measure levels of RO7565020 in the blood over time, following a single dose, in healthy participants
● Measure the body’s response to a single dose of RO7565020
● Assess the body’s immune response to RO7565020

Study Candidates

  • Males and females (on contraception)
  • Aged 18 – 65 years
  • BMI 18 – 32 kg/m2
  • Non-smokers
  • Not taking any medications

What is Involved?

Inpatient Stay: 4 nights

Follow-Up: 9 visits

Reimbursement: $8,000 (less tax)

Important Documents

Important documents to download and read

Pre-screening Form

Personal details

Please provide your name, email and phone number so we can contact you

Medical questions

Have you had any covid symptoms in the last 4 weeks or been in isolation?
Have you previously participated in a study with NZCR or any other organisation? Give details or leave blank if no
This study requires the use of contraception during the study. If you are in a hetereosexual relationship both partners must agree to use contraception (condoms for males | IUD, birth control or another approved form for females). Are you currently using 2 forms of contraception?
Have you received blood or plasma in the last 90 days? If yes please provide details
The study does not accept any current smokers. Have you used any nicotine or tobacco containing products in the last 3 months?
Any history or current autoimmune disorders? Are you being treated with any immunosuppressive medication? - For e.g., psoriasis, rheumatoid arthritis, Crohn’s disease, or ulcerative colitis etc
Are you pre-diabetic or do you have any history of diabetes?
Any history of abnormal liver or kidney conditions?
Do you have any significant heart disease or heart related conditions/abnormalities? Do you have any family history of heart conditions?
Do you have any history of allergies, asthma, hay fever, food allergies etc that you are aware of?
Any significant history of Acid reflux or peptic ulcers?
Do you have any history of clinically significant acute systemic infection and/or antibiotic treatment within 28 days?
Have you been sick in the last 30 days?
Do you have any history of medical conditions relating to:(Required)
If you have none, please select the last option.
Have you taken any prescription, vitamins, supplements, pharmacy medication or over the counter medications in the last 28 days? Please include any Vaccines in the last 3 months
Have you looked at the study dates and are okay to come in those days? Indicate which group/s you are available for. This means having flexibility for more than one group increases your chances of being accepted into a group.
Pre-screening form policy(Required)
I understand that by submitting this form, NZCR will use the information for pre-screening purposes for this study. This information may be recorded on your profile to allow us to improve our process when screening you for a future study. All information provided is confidential. I also understand that by submitting this form, I will be receiving emails, texts or calls about this study. For more information, please refer to the Privacy Policy (https://www.nzcr.co.nz/privacy-policy/).